NCT01598298
Clinical Trial Information
Trial Number: NCT01598298 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
Trial Title:
A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer
Study ID:
S1202
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01598298-D3 | This dataset will allow users to reproduce the results reported in the Journal of Clinical Oncology (Henry et al., JCO, 2017), which contains patient-level data (one row per patient), including eligibility, evaluability, treatment, demographic, and baseline information. |
| NCT01598298-D2 | This dataset will allow users to reproduce the results reported in the Journal of Clinical Oncology (Henry et al., JCO, 2017), which contains event-level information (one row per patient per adverse event experienced on trial). |
| NCT01598298-D1 | This dataset will allow users to reproduce the results reported in the Journal of Clinical Oncology (Henry et al., JCO, 2017), which contains assessment-level data (one row per patient per planned assessment time), including scores for each of the patient-completed questionnaires, days from registration to time of assessment, and whether the questionnaires were completed within the protocol-mandated time frame. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®